Skip to main content
SpringerLink
Log in

Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Introduction

Paracetamol pharmacokinetics (PK) is highly variable in older fit adults after intravenous administration. Frailty and oral administration likely result in additional variability. The aim was to determine oral paracetamol PK and variability in geriatric inpatients.

Methods

A population PK analysis, using NONMEM 7.2, was performed on 245 paracetamol samples in 40 geriatric inpatients (median age 87 [range 80–95] years, bodyweight 66.4 [49.3–110] kg, 92.5% frail [Edmonton Frail Scale]). All subjects received paracetamol 1000 mg as tablet (72.5%) or granulate (27.5%) three times daily. Simulations of dosing regimens (1000 mg every 6 hours [q6h] or q8h) were performed to determine target attainment, using mean steady-state concentration (Css-mean) of 10 mg/L as target.

Results

A one-compartment model with first order absorption and lag time best described the data. The inter-individual variability was high, with absorption rate constant containing the highest variability. The inter-individual variability could not be explained by covariates. Simulations of 1000 mg q6h and q8h resulted in a Css-mean of 10.8 [25–75th percentiles 8.2–12.7] and 8.13 [6.3–9.6] mg/L, respectively, for the average geriatric inpatient. The majority of the population remained off-target (22.2% [q6h] and 52.2% [q8h] <8 mg/L; 31.3 [q6h] and 7.6% [q8h] >12 mg/L).

Conclusion

A population of average geriatric inpatients achieved target Css-mean with paracetamol 1000 mg q6h, while q8h resulted in underexposure for the majority of them. Due to high unexplained variability, a relevant proportion remained either above or below the target concentration of 10 mg/L. Research focusing on PK, efficacy and safety is needed to recommend dosing regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gibson SJ, Lussier D. Prevalence and relevance of pain in older persons. Pain Med. 2012;13(Suppl 2):S23–6. https://doi.org/10.1111/j.1526-4637.2012.01349.x.

    Article  PubMed  Google Scholar 

  2. Molton IR, Terrill AL. Overview of persistent pain in older adults. Am Psychol. 2014;69(2):197–207. https://doi.org/10.1037/a0035794.

    Article  PubMed  Google Scholar 

  3. Marcum ZA, Duncan NA, Makris UE. Pharmacotherapies in geriatric chronic pain management. Clin Geriatr Med. 2016;32(4):705–24. https://doi.org/10.1016/j.cger.2016.06.007.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Safe acetaminophen use guideline. Goverment Q. 2014. https://www.health.qld.gov.au/__data/assets/pdf_file/0030/147666/qh-gdl-415.pdf. Accessed 15 Jun 2018.

  5. What dose of paracetamol for older people? Drug Ther Bull. 2018;56(6):69–72. https://doi.org/10.1136/dtb.2018.6.0636.

  6. Boparai MK, Korc-Grodzicki B. Prescribing for older adults. Mt Sinai J Med. 2011;78(4):613–26. https://doi.org/10.1002/msj.20278.

    Article  PubMed  Google Scholar 

  7. ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther. 2007;14(5):488–98. https://doi.org/10.1097/01.mjt.0000183719.84390.4d.

    Article  PubMed  Google Scholar 

  8. Allegaert K, Olkkola KT, Owens KH, Van de Velde M, de Maat MM, Anderson BJ, et al. Covariates of intravenous paracetamol pharmacokinetics in adults. BMC Anesthesiol. 2014;14:77. https://doi.org/10.1186/1471-2253-14-77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bannwarth B, Pehourcq F, Lagrange F, Matoga M, Maury S, Palisson M, et al. Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain. J Rheumatol. 2001;28(1):182–4.

    CAS  PubMed  Google Scholar 

  10. Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Niemi M, Neuvonen PJ, et al. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet. 2011;50(2):121–9. https://doi.org/10.2165/11537240-000000000-00000.

    Article  CAS  PubMed  Google Scholar 

  11. Johnston C, Hilmer SN, McLachlan AJ, Matthews ST, Carroll PR, Kirkpatrick CM. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol. 2014;70(5):549–55. https://doi.org/10.1007/s00228-014-1652-7.

    Article  CAS  PubMed  Google Scholar 

  12. Rockwood K, Howlett SE. Fifteen years of progress in understanding frailty and health in aging. BMC Med. 2018;16(1):220. https://doi.org/10.1186/s12916-018-1223-3.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ellmers SEPL, Notarianni LJ, Jones RW. Excretion of paracetamol in fit and frail elderly people. J Am Geriatr Soc. 1991;31(596):597.

    Google Scholar 

  14. Wynne HA, Cope LH, Herd B, Rawlins MD, James OF, Woodhouse KW. The association of age and frailty with paracetamol conjugation in man. Age Ageing. 1990;19(6):419–24.

    Article  CAS  Google Scholar 

  15. Mian P, van Esdonk MJ, Olkkola KT, de Winter BCM, Liukas A, Spriet I, et al. Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability. Br J Clin Pharmacol. 2019;85(1):126–35. https://doi.org/10.1111/bcp.13770.

    Article  CAS  PubMed  Google Scholar 

  16. Corsi N, Roberto A, Cortesi L, Nobili A, Mannucci PM, Corli O, et al. Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards. Eur J Intern Med. 2018;55:35–9. https://doi.org/10.1016/j.ejim.2018.05.031.

    Article  PubMed  Google Scholar 

  17. Gibb IA, Anderson BJ. Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child. 2008;93(3):241–7. https://doi.org/10.1136/adc.2007.126896.

    Article  CAS  PubMed  Google Scholar 

  18. Hias J, Van der Linden L, Walgraeve K, Gijsen M, Mian P, Koch BCP, Allegaert K, Annaert P, Tournoy J, Spriet I. Pharmacokinetics of 2 oral paracetamol formulations in hospitalized octogenarians. Br J Clin Pharmacol. 2021. https://doi.org/10.1111/bcp.15049

    Article  PubMed  Google Scholar 

  19. Flint RB, Mian P, van der Nagel B, Slijkhuis N, Koch BC. Quantification of acetaminophen and its metabolites in plasma using UPLC-MS: doors open to therapeutic drug monitoring in special patient populations. Ther Drug Monit. 2017;39(2):164–71. https://doi.org/10.1097/FTD.0000000000000379.

    Article  CAS  PubMed  Google Scholar 

  20. Nguyen TH, Mouksassi MS, Holford N, Al-Huniti N, Freedman I, Hooker AC, et al. Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacometrics Syst Pharmacol. 2017;6(2):87–109. https://doi.org/10.1002/psp4.12161.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Savic RM, Jonker DM, Kerbusch T, Karlsson MO. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 2007;34(5):711–26. https://doi.org/10.1007/s10928-007-9066-0.

    Article  CAS  PubMed  Google Scholar 

  22. Petersson KJ, Hanze E, Savic RM, Karlsson MO. Semiparametric distributions with estimated shape parameters. Pharm Res. 2009;26(9):2174–85. https://doi.org/10.1007/s11095-009-9931-1.

    Article  CAS  PubMed  Google Scholar 

  23. Rodriguez-Manas L, Feart C, Mann G, Vina J, Chatterji S, Chodzko-Zajko W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–7. https://doi.org/10.1093/gerona/gls119.

    Article  PubMed  Google Scholar 

  24. Cerreta F, Eichler HG, Rasi G. Drug policy for an aging population–the European Medicines Agency’s geriatric medicines strategy. N Engl J Med. 2012;367(21):1972–4. https://doi.org/10.1056/NEJMp1209034.

    Article  CAS  PubMed  Google Scholar 

  25. Booker SS, Bartoszczyk DA, Herr KA. Managing pain in frail elders. Am Nurse Today. 2016;11(4). https://www.americannursetoday.com/managing-pain-frail-elders/

  26. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol. 2002;40(1):3–20.

    Article  CAS  Google Scholar 

  27. Miners JO, Penhall R, Robson RA, Birkett DJ. Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol. 1988;35(2):157–60.

    Article  CAS  Google Scholar 

  28. Bos JC, Misticio MC, Nunguiane G, Mathot RAA, van Hest RM, Prins JM. Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study. BMC Res Notes. 2017;10(1):671. https://doi.org/10.1186/s13104-017-3016-8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Sabate M, Ibanez L, Perez E, Vidal X, Buti M, Xiol X, et al. Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. BMC Gastroenterol. 2011;11:80. https://doi.org/10.1186/1471-230X-11-80.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ging P, Mikulich O, O’Reilly KM. Unexpected paracetamol (acetaminophen) hepatotoxicity at standard dosage in two older patients: time to rethink 1 g four times daily? Age Ageing. 2016;45(4):566–7. https://doi.org/10.1093/ageing/afw067.

    Article  PubMed  Google Scholar 

  31. Mitchell SJ, Kane AE, Hilmer SN. Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res. 2011;2011: 624156. https://doi.org/10.1155/2011/624156.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Valente MA, Hillege HL, Navis G, Voors AA, Dunselman PH, van Veldhuisen DJ, et al. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail. 2014;16(1):86–94. https://doi.org/10.1093/eurjhf/hft128.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We greatly acknowledge K. Hagoort for editorial assistance.

Author information

Author notes

  1. L. T. van der Heijden and P. Mian contributed equally.

Authors and Affiliations

  1. Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands

    L. T. van der Heijden, P. Mian & D. Tibboel

  2. Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands

    L. T. van der Heijden

  3. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713 GZ, The Netherlands

    P. Mian

  4. Pharmacy Department, University Hospitals Leuven, Leuven, Belgium

    J. Hias, L. Van der Linden, K. Walgraeve & I. Spriet

  5. Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands

    B. C. M. de Winter, B. C. P. Koch & K. Allegaert

  6. Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium

    J. Tournoy & J. Flamaing

  7. Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium

    J. Tournoy & J. Flamaing

  8. Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

    L. Van der Linden, K. Allegaert & I. Spriet

  9. Department of Development and Regeneration, KU Leuven, Leuven, Belgium

    K. Allegaert

Authors
  1. L. T. van der Heijden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Mian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Hias
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. C. M. de Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Tournoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Van der Linden
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Tibboel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. Walgraeve
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Flamaing
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. B. C. P. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. K. Allegaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. I. Spriet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Mian.

Ethics declarations

Funding

All authors declare that no funding for this project has been received.

Conflict of interest

All authors declare no conflicts of interest.

Ethics approval

This study was conducted at the University Hospitals Leuven, Belgium, following approval by the medical ethics committee of UZ Leuven (EUDRACT 2015-004217-24).

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Data availability

The data that support the findings of this study are available on request from the corresponding author.

Code availability

Available upon request to the corresponding author.

Author contributions

LvdH and PM wrote the manuscript; LvdH, PM, LvdL, JH, BK, BdW, DT, JT, JF, KW, and IS edited the manuscript; LvdH and PM provided graphics for the manuscript; LvdH, PM, KA, BK and BdW performed research for the manuscript; LvdH, PM, KA, IS, BK and BdW designed the research; and IS, KA, BK and BdW supervised the research. All authors read and approved the final version of the paper.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van der Heijden, L.T., Mian, P., Hias, J. et al. Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis. Drugs Aging 39, 83–95 (2022). https://doi.org/10.1007/s40266-021-00912-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-021-00912-z

Search

Navigation